Stock listing
KRRO Stock Price, News, Filings & Events — Korro Bio, Inc.
Selected listing: KRRO · NASDAQ · USD · US
This page tracks Korro Bio, Inc.'s KRRO:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following KRRO:NASDAQ. KRRO:NASDAQ is the stock-level entry point for investors researching Korro Bio, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Korro Bio, Inc. (KRRO) is listed on 6ix with investor news, events, company updates, and market data in one place. Follow the company page to track new releases, upcoming presentations, and the latest information available on 6ix.
- Ticker
- KRRO:NASDAQ
- Asset type
- Stock
- Market cap
- $190.1M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
Korro Bio, Inc. KRRO:NASDAQ stock context
This page tracks Korro Bio, Inc.'s KRRO:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following KRRO:NASDAQ. KRRO:NASDAQ is the stock-level entry point for investors researching Korro Bio, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Korro Bio, Inc. (KRRO) is listed on 6ix with investor news, events, company updates, and market data in one place. Follow the company page to track new releases, upcoming presentations, and the latest information available on 6ix.
Latest news from Korro Bio, Inc.
Korro Reports Second Quarter 2026 Financial Results and Provides Corporate Update
August 6, 2026
Korro Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 10, 2026
Korro to Present at the 2026 Jefferies Global Healthcare Conference
May 27, 2026
Korro Selects KRRO-111 as Development Candidate for the Potential Treatment of Alpha-1 Antitrypsin Deficiency
May 20, 2026
Korro Selects KRRO-111 as Development Candidate for the Potential Treatment of Alpha-1 Antitrypsin Deficiency (AATD)
May 19, 2026
Research Korro Bio, Inc.
Korro Bio, Inc. investor report
Review AI stock analysis and investor report context for KRRO:NASDAQ.
Korro Bio, Inc. company profile
View the public company page for Korro Bio, Inc. on 6ix.
Korro Bio, Inc. news
Read company news and market updates connected to Korro Bio, Inc..
Korro Bio, Inc. investor events
Find investor webinars, events, and replay context for Korro Bio, Inc..